Escalon Medical Corp.: 10-Q filed 2015-02-13
What Escalon Medical Corp. reported in its quarterly report filed 2015-02-13 (fiscal Q2 2015): 33 published measures, 94 facts as tagged in accession 0000862668-15-000002.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-02-13
- Fiscal period
- fiscal Q2 2015
- Accession
- 0000862668-15-000002 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Escalon Medical Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 6,724,358 | USD | |
| At 2014-06-30 | 7,656,274 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 3,758,821 | USD | |
| At 2014-06-30 | 4,192,451 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 2,965,537 | USD | |
| At 2014-06-30 | 3,463,823 | USD | |
| At 2013-06-30 | 3,463,823 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,319,184 | USD | |
| At 2014-06-30 | 2,009,554 | USD | |
| At 2013-12-31 | 2,565,156 | USD | |
| At 2010-06-30 | 2,654,701 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -74,089 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -533,048 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -108,549 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -95,309 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -668,093 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -70,715 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -22,277 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -18,830 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -66,639,273 | USD | |
| At 2014-06-30 | -66,106,225 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 7,526,430 | shares | 92 |
| 2014-07-01 to 2014-12-31 | 7,526,430 | shares | 184 |
| 2013-10-01 to 2013-12-31 | 7,526,430 | shares | 92 |
| 2013-07-01 to 2013-12-31 | 7,526,430 | shares | 184 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 7,526,430 | shares | 92 |
| 2014-07-01 to 2014-12-31 | 7,526,430 | shares | 184 |
| 2013-10-01 to 2013-12-31 | 7,526,430 | shares | 92 |
| 2013-07-01 to 2013-12-31 | 7,526,430 | shares | 184 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -0.01 | USD/shares | 92 |
| 2014-07-01 to 2014-12-31 | -0.07 | USD/shares | 184 |
| 2013-10-01 to 2013-12-31 | -0.01 | USD/shares | 92 |
| 2013-07-01 to 2013-12-31 | -0.01 | USD/shares | 184 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -0.01 | USD/shares | 92 |
| 2014-07-01 to 2014-12-31 | -0.07 | USD/shares | 184 |
| 2013-10-01 to 2013-12-31 | -0.01 | USD/shares | 92 |
| 2013-07-01 to 2013-12-31 | -0.01 | USD/shares | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 40,702 | USD | |
| At 2014-06-30 | 24,456 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -76,774 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -517,009 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -89,306 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -51,590 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 5,949,623 | USD | |
| At 2014-06-30 | 6,896,985 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 2,947,174 | USD | |
| At 2014-06-30 | 3,350,752 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,100,861 | USD | |
| At 2014-06-30 | 1,486,081 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 125,027 | USD | |
| At 2014-06-30 | 125,027 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 4,000 | USD | |
| At 2014-06-30 | 4,800 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 2,030,200 | USD | |
| At 2014-06-30 | 1,690,156 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 2,384,630 | USD | |
| At 2014-06-30 | 2,910,727 | USD | |
| At 2013-06-30 | 2,910,727 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 1,489,627 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 2,869,008 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 1,280,427 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 2,493,390 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 383,727 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 708,004 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 377,042 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 700,232 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 7,526,430 | shares | |
| At 2013-06-30 | 7,526,430 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 69,597,284 | USD | |
| At 2014-06-30 | 69,562,522 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,135,481 | USD | |
| At 2014-06-30 | 1,169,943 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -76,748 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -516,944 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -82,715 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -43,870 | USD | 184 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -76,748 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -516,944 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -82,715 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -43,870 | USD | 184 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 6,831 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 4,597 | USD | 184 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 0 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 0 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 6,535 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 7,603 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 26 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 65 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 6,591 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 7,720 | USD | 184 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 340,044 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -38,284 | USD | 184 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -526,097 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 381,802 | USD | 184 |
Inspect the source
- Entity
- Escalon Medical Corp. / CIK 0000862668
- Captured
- 2026-09-20T04:59:43.148Z
- SEC response SHA-256
1553c3790334a15d4c4528d0e1ce16eac37d12130ed9cd66f6b338c07ce2533d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000862668.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))